Insilico Medicine Execs at CPIC Discuss AI Drug Discovery’s Tech and Clinical Breakthroughs
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug ...
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug ...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global ...
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, is set to headline BIO Asia-Taiwan 2026, the region’s premier biotechnology ...
In the labyrinthine world of drug discovery, the quest to develop new medications is a marathon marked by thousands of ...
Machine Learning Uncovers New Antibiotics to Combat Resistant Gonorrhea The relentless surge of antibiotic-resistant gonorrhea poses an escalating threat to ...
In a groundbreaking recognition that underscores the rapidly evolving confluence of artificial intelligence and biotechnology, Alex Zhavoronkov, Founder and CEO ...
In the rapidly evolving landscape of therapeutic antibody development, efficiency and precision remain paramount challenges. Antibodies, as cornerstone molecules in ...
In an ambitious leap forward for pharmaceutical science, researchers at the University of Virginia School of Medicine have unveiled a ...
Insilico Medicine Accelerates Oncology Innovation with Four Novel AI-Designed Programs Unveiled at AACR 2026 In a striking demonstration of the ...
In a groundbreaking publication poised to redefine the future of drug discovery, researchers from Insilico Medicine and Lilly have unveiled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine